The 3rd Allogeneic Cell Therapies Summit Europe returned in January providing a unique opportunity to connect with the community pioneering best-in-class scalable off-the-shelf therapies in Europe

Allogeneic therapies provide the next generation for cell therapies, however, multiple challenges are impeding development, including efficient cell engineering, scalable manufacturing, and cryopreservation. In 2024, our event delegates were seeking solutions and industry partners to aid their therapy development- this was the opportunity to connect and create relationships.